{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:05:27Z","timestamp":1794405927114,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","award":["Innovator Grant"],"award-info":[{"award-number":["Innovator Grant"]}],"id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","award":["Innovator Grant"],"award-info":[{"award-number":["Innovator Grant"]}],"id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016887","name":"Motor Neurone Disease Research Australia","doi-asserted-by":"publisher","award":["Bill Gole Fellowship"],"award-info":[{"award-number":["Bill Gole Fellowship"]}],"id":[{"id":"10.13039\/100016887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Forefront Research"},{"name":"ForeFront Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Multiple neurotoxic proteinopathies co-exist within vulnerable neuronal populations in all major neurodegenerative diseases. Interactions between these pathologies may modulate disease progression, suggesting they may constitute targets for disease-modifying treatments aiming to slow or halt neurodegeneration. Pairwise interactions between superoxide dismutase 1 (SOD1), TAR DNA-binding protein 43 (TDP-43) and ubiquitin-binding protein 62\/sequestosome 1 (p62) proteinopathies have been reported in multiple transgenic cellular and animal models of amyotrophic lateral sclerosis (ALS), however corresponding examination of these relationships in patient tissues is lacking. Further, the coalescence of all three proteinopathies has not been studied in vitro or in vivo to date. These data are essential to guide therapeutic development and enhance the translation of relevant therapies into the clinic. Our group recently profiled SOD1 proteinopathy in post-mortem spinal cord tissues from familial and sporadic ALS cases, demonstrating an abundance of structurally-disordered (dis)SOD1 conformers which become mislocalized within these vulnerable neurons compared with those of aged controls. To explore any relationships between this, and other, ALS-linked proteinopathies, we profiled TDP-43 and p62 within spinal cord motor neurons of the same post-mortem tissue cohort using multiplexed immunofluorescence and immunohistochemistry. We identified distinct patterns of SOD1, TDP43 and p62 co-deposition and subcellular mislocalization between motor neurons of familial and sporadic ALS cases, which we primarily attribute to\n                    <jats:italic>SOD1<\/jats:italic>\n                    gene status. Our data demonstrate co-deposition of p62 with mutant and wild-type disSOD1 and phosphorylated TDP-43 in familial and sporadic ALS spinal cord motor neurons, consistent with attempts by p62 to mitigate SOD1 and TDP-43 deposition. Wild-type SOD1 and TDP-43 co-deposition was also frequently observed in ALS cases lacking\n                    <jats:italic>SOD1<\/jats:italic>\n                    mutations. Finally, alterations to the subcellular localization of the three proteins were tightly correlated, suggesting close relationships between the regulatory mechanisms governing the subcellular compartmentalization of these proteins. Our study is the first to profile spatial relationships between SOD1, TDP-43 and p62 pathologies in post-mortem spinal cord motor neurons of ALS patients, previously only studied in vitro. Our findings suggest interactions between these three key ALS-linked proteins are likely to modulate the formation of their respective proteinopathies, and perhaps the rate of motor neuron degeneration, in ALS patients.\n                  <\/jats:p>","DOI":"10.1186\/s40478-022-01421-9","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T04:03:36Z","timestamp":1661400216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration"],"prefix":"10.1186","volume":"10","author":[{"given":"Benjamin G.","family":"Trist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Fifita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Grima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Troakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Vance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Al-Sarraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-7781","authenticated-orcid":false,"given":"Kay L.","family":"Double","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9112413","author":"A Amin","year":"2020","unstructured":"Amin A, Perera ND, Beart PM, Turner BJ, Shabanpoor F (2020) Amyotrophic lateral sclerosis and autophagy: dysfunction and therapeutic targeting. Cells. https:\/\/doi.org\/10.3390\/cells9112413","journal-title":"Cells"},{"key":"1421_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jnc.12493","volume":"129","author":"JD Atkin","year":"2014","unstructured":"Atkin JD, Farg MA, Soo KY, Walker AK, Halloran M, Turner BJ, Nagley P, Horne MK (2014) Mutant SOD1 inhibits ER-Golgi transport in amyotrophic lateral sclerosis. J Neurochem 129:190\u2013204. https:\/\/doi.org\/10.1111\/jnc.12493","journal-title":"J Neurochem"},{"key":"1421_CR3","doi-asserted-by":"publisher","first-page":"e565","DOI":"10.1212\/WNL.0000000000004960","volume":"90","author":"M Benatar","year":"2018","unstructured":"Benatar M, Wuu J, Andersen PM, Atassi N, David W, Cudkowicz M, Schoenfeld D (2018) Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology 90:e565\u2013e574. https:\/\/doi.org\/10.1212\/WNL.0000000000004960","journal-title":"Neurology"},{"key":"1421_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fnins.2019.00335","volume":"13","author":"BA Berning","year":"2019","unstructured":"Berning BA, Walker AK (2019) The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front Neurosci 13:335. https:\/\/doi.org\/10.3389\/fnins.2019.00335","journal-title":"Front Neurosci"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.07098.x","volume":"116","author":"OA Brady","year":"2011","unstructured":"Brady OA, Meng P, Zheng Y, Mao Y, Hu F (2011) Regulation of TDP-43 aggregation by phosphorylation and p62\/SQSTM1. J Neurochem 116:248\u2013259. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07098.x","journal-title":"J Neurochem"},{"key":"1421_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/bph.15148","volume":"178","author":"E Buratti","year":"2021","unstructured":"Buratti E (2021) Targeting TDP-43 proteinopathy with drugs and drug-like small molecules. Br J Pharmacol 178:1298\u20131315. https:\/\/doi.org\/10.1111\/bph.15148","journal-title":"Br J Pharmacol"},{"key":"1421_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.4161\/auto.25188","volume":"9","author":"K Castillo","year":"2013","unstructured":"Castillo K, Nassif M, Valenzuela V, Rojas F, Matus S, Mercado G, Court FA, van Zundert B, Hetz C (2013) Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9:1308\u20131320. https:\/\/doi.org\/10.4161\/auto.25188","journal-title":"Autophagy"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"e20423","DOI":"10.1097\/MD.0000000000020423","volume":"99","author":"PC Chen","year":"2020","unstructured":"Chen PC, Hsieh YC, Huang CC, Hu CJ (2020) Tamoxifen for amyotrophic lateral sclerosis: a randomized double-blind clinical trial. Medicine (Baltimore) 99:e20423. https:\/\/doi.org\/10.1097\/MD.0000000000020423","journal-title":"Medicine (Baltimore)"},{"key":"1421_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbrc.2020.03.051","volume":"526","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang H, Ying Z, Gao Q (2020) Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: the new molecular mechanism of ibudilast and its implication for neuroprotective therapy. Biochem Biophys Res Commun 526:231\u2013238. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.051","journal-title":"Biochem Biophys Res Commun"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/stem.2388","volume":"34","author":"R Dafinca","year":"2016","unstructured":"Dafinca R, Scaber J, Ababneh N, Lalic T, Weir G, Christian H, Vowles J, Douglas AG, Fletcher-Jones A, Browne C et al (2016) C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem Cells 34:2063\u20132078. https:\/\/doi.org\/10.1002\/stem.2388","journal-title":"Stem Cells"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.22051","volume":"67","author":"HX Deng","year":"2010","unstructured":"Deng HX, Zhai H, Bigio EH, Yan J, Fecto F, Ajroud K, Mishra M, Ajroud-Driss S, Heller S, Sufit R et al (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67:739\u2013748. https:\/\/doi.org\/10.1002\/ana.22051","journal-title":"Ann Neurol"},{"key":"1421_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/1873-3468.12646","volume":"591","author":"H Ederle","year":"2017","unstructured":"Ederle H, Dormann D (2017) TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett 591:1489\u20131507. https:\/\/doi.org\/10.1002\/1873-3468.12646","journal-title":"FEBS Lett"},{"key":"1421_CR13","doi-asserted-by":"publisher","first-page":"101700","DOI":"10.1016\/j.isci.2020.101700","volume":"23","author":"NE Farrawell","year":"2020","unstructured":"Farrawell NE, McAlary L, Lum JS, Chisholm CG, Warraich ST, Blair IP, Vine KL, Saunders DN, Yerbury JJ (2020) Ubiquitin homeostasis is disrupted in TDP-43 and FUS cell models of ALS. iScience 23:101700. https:\/\/doi.org\/10.1016\/j.isci.2020.101700","journal-title":"iScience"},{"key":"1421_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/jnnp-2018-319386","volume":"90","author":"K Forsberg","year":"2019","unstructured":"Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, Brannstrom T, Andersen PM (2019) Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS\/FTD-associated genes. J Neurol Neurosurg Psychiatry 90:861\u2013869. https:\/\/doi.org\/10.1136\/jnnp-2018-319386","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1421_CR15","doi-asserted-by":"publisher","first-page":"e11552","DOI":"10.1371\/journal.pone.0011552","volume":"5","author":"K Forsberg","year":"2010","unstructured":"Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T (2010) Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE 5:e11552. https:\/\/doi.org\/10.1371\/journal.pone.0011552","journal-title":"PLoS ONE"},{"key":"1421_CR16","doi-asserted-by":"publisher","first-page":"24167","DOI":"10.1074\/jbc.M802083200","volume":"283","author":"Y Furukawa","year":"2008","unstructured":"Furukawa Y, Kaneko K, Yamanaka K, O\u2019Halloran TV, Nukina N (2008) Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J Biol Chem 283:24167\u201324176. https:\/\/doi.org\/10.1074\/jbc.M802083200","journal-title":"J Biol Chem"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"11068","DOI":"10.1074\/jbc.M608787200","volume":"282","author":"J Gal","year":"2007","unstructured":"Gal J, Strom AL, Kilty R, Zhang F, Zhu H (2007) p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem 282:11068\u201311077. https:\/\/doi.org\/10.1074\/jbc.M608787200","journal-title":"J Biol Chem"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1471-4159.2009.06388.x","volume":"111","author":"J Gal","year":"2009","unstructured":"Gal J, Strom AL, Kwinter DM, Kilty R, Zhang J, Shi P, Fu W, Wooten MW, Zhu H (2009) Sequestosome 1\/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J Neurochem 111:1062\u20131073. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06388.x","journal-title":"J Neurochem"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1073\/pnas.1115402109","volume":"109","author":"S Guareschi","year":"2012","unstructured":"Guareschi S, Cova E, Cereda C, Ceroni M, Donetti E, Bosco DA, Trotti D, Pasinelli P (2012) An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci U S A 109:5074\u20135079. https:\/\/doi.org\/10.1073\/pnas.1115402109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1421_CR20","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1093\/hmg\/ddw180","volume":"25","author":"S Hadano","year":"2016","unstructured":"Hadano S, Mitsui S, Pan L, Otomo A, Kubo M, Sato K, Ono S, Onodera W, Abe K, Chen X et al (2016) Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum Mol Genet 25:3321\u20133340. https:\/\/doi.org\/10.1093\/hmg\/ddw180","journal-title":"Hum Mol Genet"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60\u201370. https:\/\/doi.org\/10.1002\/ana.21425","journal-title":"Ann Neurol"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40035-020-00219-w","volume":"9","author":"C Huang","year":"2020","unstructured":"Huang C, Yan S, Zhang Z (2020) Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases. Transl Neurodegener 9:40. https:\/\/doi.org\/10.1186\/s40035-020-00219-w","journal-title":"Transl Neurodegener"},{"key":"1421_CR23","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s12035-018-1218-2","volume":"56","author":"GS Jeon","year":"2019","unstructured":"Jeon GS, Shim YM, Lee DY, Kim JS, Kang M, Ahn SH, Shin JY, Geum D, Hong YH, Sung JJ (2019) Pathological modification of TDP-43 in amyotrophic lateral sclerosis with SOD1 mutations. Mol Neurobiol 56:2007\u20132021. https:\/\/doi.org\/10.1007\/s12035-018-1218-2","journal-title":"Mol Neurobiol"},{"key":"1421_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","volume":"21","author":"WJ Liu","year":"2016","unstructured":"Liu WJ, Ye L, Huang WF, Guo LJ, Xu ZG, Wu HL, Yang C, Liu HF (2016) p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett 21:29. https:\/\/doi.org\/10.1186\/s11658-016-0031-z","journal-title":"Cell Mol Biol Lett"},{"key":"1421_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434. https:\/\/doi.org\/10.1002\/ana.21147","journal-title":"Ann Neurol"},{"key":"1421_CR26","doi-asserted-by":"publisher","first-page":"e11119","DOI":"10.1097\/MD.0000000000011119","volume":"97","author":"J Mandrioli","year":"2018","unstructured":"Mandrioli J, D\u2019Amico R, Zucchi E, Gessani A, Fini N, Fasano A, Caponnetto C, Chio A, Dalla Bella E, Lunetta C et al (2018) Rapamycin treatment for amyotrophic lateral sclerosis: protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial). Medicine (Baltimore) 97:e11119. https:\/\/doi.org\/10.1097\/MD.0000000000011119","journal-title":"Medicine (Baltimore)"},{"key":"1421_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00401-019-01998-x","volume":"138","author":"L Marrone","year":"2019","unstructured":"Marrone L, Drexler HCA, Wang J, Tripathi P, Distler T, Heisterkamp P, Anderson EN, Kour S, Moraiti A, Maharana S et al (2019) FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol 138:67\u201384. https:\/\/doi.org\/10.1007\/s00401-019-01998-x","journal-title":"Acta Neuropathol"},{"key":"1421_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12973","author":"EP McCann","year":"2017","unstructured":"McCann EP, Williams KL, Fifita JA, Tarr IS, O\u2019Connor J, Rowe DB, Nicholson GA, Blair IP (2017) The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clin Genet. https:\/\/doi.org\/10.1111\/cge.12973","journal-title":"Clin Genet"},{"key":"1421_CR29","doi-asserted-by":"publisher","first-page":"8209","DOI":"10.1073\/pnas.1801109115","volume":"115","author":"DB Medinas","year":"2018","unstructured":"Medinas DB, Rozas P, Martinez Traub F, Woehlbier U, Brown RH, Bosco DA, Hetz C (2018) Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 115:8209\u20138214. https:\/\/doi.org\/10.1073\/pnas.1801109115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1421_CR30","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1093\/hmg\/ddx274","volume":"26","author":"DB Medinas","year":"2017","unstructured":"Medinas DB, Valenzuela V, Hetz C (2017) Proteostasis disturbance in amyotrophic lateral sclerosis. Hum Mol Genet 26:R91\u2013R104. https:\/\/doi.org\/10.1093\/hmg\/ddx274","journal-title":"Hum Mol Genet"},{"key":"1421_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","volume":"383","author":"T Miller","year":"2020","unstructured":"Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL et al (2020) Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med 383:109\u2013119. https:\/\/doi.org\/10.1056\/NEJMoa2003715","journal-title":"N Engl J Med"},{"key":"1421_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13041-018-0373-8","volume":"11","author":"S Mitsui","year":"2018","unstructured":"Mitsui S, Otomo A, Nozaki M, Ono S, Sato K, Shirakawa R, Adachi H, Aoki M, Sobue G, Shang HF et al (2018) Systemic overexpression of SQSTM1\/p62 accelerates disease onset in a SOD1(H46R)-expressing ALS mouse model. Mol Brain 11:30. https:\/\/doi.org\/10.1186\/s13041-018-0373-8","journal-title":"Mol Brain"},{"key":"1421_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jns.2006.05.060","volume":"249","author":"Y Mizuno","year":"2006","unstructured":"Mizuno Y, Amari M, Takatama M, Aizawa H, Mihara B, Okamoto K (2006) Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci 249:13\u201318. https:\/\/doi.org\/10.1016\/j.jns.2006.05.060","journal-title":"J Neurol Sci"},{"key":"1421_CR34","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1074\/jbc.M115.695379","volume":"291","author":"T Nonaka","year":"2016","unstructured":"Nonaka T, Suzuki G, Tanaka Y, Kametani F, Hirai S, Okado H, Miyashita T, Saitoe M, Akiyama H, Masai H et al (2016) Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1delta triggers mislocalization and accumulation of TDP-43. J Biol Chem 291:5473\u20135483. https:\/\/doi.org\/10.1074\/jbc.M115.695379","journal-title":"J Biol Chem"},{"key":"1421_CR35","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1074\/jbc.M109.039925","volume":"285","author":"S Pankiv","year":"2010","unstructured":"Pankiv S, Lamark T, Bruun JA, Overvatn A, Bjorkoy G, Johansen T (2010) Nucleocytoplasmic shuttling of p62\/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem 285:5941\u20135953. https:\/\/doi.org\/10.1074\/jbc.M109.039925","journal-title":"J Biol Chem"},{"key":"1421_CR36","doi-asserted-by":"publisher","first-page":"e35050","DOI":"10.1371\/journal.pone.0035050","volume":"7","author":"E Pokrishevsky","year":"2012","unstructured":"Pokrishevsky E, Grad LI, Yousefi M, Wang J, Mackenzie IR, Cashman NR (2012) Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. PLoS ONE 7:e35050. https:\/\/doi.org\/10.1371\/journal.pone.0035050","journal-title":"PLoS ONE"},{"key":"1421_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257\u2013268. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.010","journal-title":"Neuron"},{"key":"1421_CR38","doi-asserted-by":"publisher","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","volume":"34","author":"BR Roberts","year":"2014","unstructured":"Roberts BR, Lim NK, McAllum EJ, Donnelly PS, Hare DJ, Doble PA, Turner BJ, Price KA, Lim SC, Paterson BM et al (2014) Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci 34:8021\u20138031. https:\/\/doi.org\/10.1523\/JNEUROSCI.4196-13.2014","journal-title":"J Neurosci"},{"key":"1421_CR39","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neulet.2007.03.066","volume":"420","author":"J Robertson","year":"2007","unstructured":"Robertson J, Sanelli T, Xiao S, Yang W, Horne P, Hammond R, Pioro EP, Strong MJ (2007) Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett 420:128\u2013132. https:\/\/doi.org\/10.1016\/j.neulet.2007.03.066","journal-title":"Neurosci Lett"},{"key":"1421_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, Oregan JP, Deng HX et al (1993) Mutations in Cu\/Zn Superoxide-dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362. https:\/\/doi.org\/10.1038\/362059a0","journal-title":"Nature"},{"key":"1421_CR41","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-015-1468-2","volume":"130","author":"KY Soo","year":"2015","unstructured":"Soo KY, Halloran M, Sundaramoorthy V, Parakh S, Toth RP, Southam KA, McLean CA, Lock P, King A, Farg MA et al (2015) Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol 130:679\u2013697. https:\/\/doi.org\/10.1007\/s00401-015-1468-2","journal-title":"Acta Neuropathol"},{"key":"1421_CR42","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto C, Pritzkow S (2018) Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 21:1332\u20131340. https:\/\/doi.org\/10.1038\/s41593-018-0235-9","journal-title":"Nat Neurosci"},{"key":"1421_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones TL, Attems J, Thal DR (2017) Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol 134:187\u2013205. https:\/\/doi.org\/10.1007\/s00401-017-1709-7","journal-title":"Acta Neuropathol"},{"key":"1421_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-020-00397-1","volume":"15","author":"TR Suk","year":"2020","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15:45. https:\/\/doi.org\/10.1186\/s13024-020-00397-1","journal-title":"Mol Neurodegener"},{"key":"1421_CR45","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1007\/s00018-013-1385-2","volume":"70","author":"V Sundaramoorthy","year":"2013","unstructured":"Sundaramoorthy V, Walker AK, Yerbury J, Soo KY, Farg MA, Hoang V, Zeineddine R, Spencer D, Atkin JD (2013) Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol Life Sci 70:4181\u20134195. https:\/\/doi.org\/10.1007\/s00018-013-1385-2","journal-title":"Cell Mol Life Sci"},{"key":"1421_CR46","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/jnr.23081","volume":"90","author":"K Tanji","year":"2012","unstructured":"Tanji K, Zhang HX, Mori F, Kakita A, Takahashi H, Wakabayashi K (2012) p62\/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J Neurosci Res 90:2034\u20132042. https:\/\/doi.org\/10.1002\/jnr.23081","journal-title":"J Neurosci Res"},{"key":"1421_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac165","author":"BG Trist","year":"2022","unstructured":"Trist BG, Genoud S, Roudeau S, Rookyard A, Abdeen A, Cottam V, Hare DJ, White M, Altvater J, Fifita JA et al (2022) Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord. Brain. https:\/\/doi.org\/10.1093\/brain\/awac165","journal-title":"Brain"},{"key":"1421_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202000451","author":"BG Trist","year":"2020","unstructured":"Trist BG, Hilton JB, Hare DJ, Crouch PJ, Double KL (2020) Superoxide dismutase 1 in health and disease: how a frontline antioxidant becomes neurotoxic. Angew Chem Int Ed Engl. https:\/\/doi.org\/10.1002\/anie.202000451","journal-title":"Angew Chem Int Ed Engl"},{"key":"1421_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","volume":"89","author":"JR Williams","year":"2016","unstructured":"Williams JR, Trias E, Beilby PR, Lopez NI, Labut EM, Bradford CS, Roberts BR, McAllum EJ, Crouch PJ, Rhoads TW et al (2016) Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD. Neurobiol Dis 89:1\u20139. https:\/\/doi.org\/10.1016\/j.nbd.2016.01.020","journal-title":"Neurobiol Dis"},{"key":"1421_CR50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12192-017-0804-y","volume":"22","author":"R Zeineddine","year":"2017","unstructured":"Zeineddine R, Farrawell NE, Lambert-Smith IA, Yerbury JJ (2017) Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregation. Cell Stress Chaperones 22:893\u2013902. https:\/\/doi.org\/10.1007\/s12192-017-0804-y","journal-title":"Cell Stress Chaperones"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01421-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01421-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01421-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T04:07:28Z","timestamp":1661400448000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01421-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01421-9","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the University of Sydney Human Research Ethics Committee (approval number 2019\/309).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}